Learn More
A series of experiments indicated that 125I-parathyroid hormone administered to the rat i.v. was deposited very rapidly in three organ systems only, bone, kidney and the liver. As indicated by increasing solubility in trichloracetic acid, the hormone seemed to be rapidly metabolized at the sites of deposition. The experiments were in part repeated employing(More)
Autoradiographs were prepared from tissues of rats sacrificed 10 minutes after injection of biologically active 125I-labeled parathyroid hormone. No radioactivity was seen in intestine and muscle. Deposition in liver was diffuse showing some sinusoidal concentrations. Depostion in kidney was high and, nearly all activity appeared in selected tubules(More)
Further studies on the preparation of 125I-labeled, biologically active parathyroid hormone have resulted in improvements in the procedure, in the storage of the labeled product, and in the establisment of the location of the label in the polypeptide chain. Approximately 95% of the label is on the single tyrosyl residue, amino acid 43, in the bovine(More)
Biologically active 125I-labeled parathyroid hormone (125I-PTH) was used in a series of studies in dogs and chickens designed to confirm and augment earlier studies in rats. As in rats, a three exponential equation was required to describe disappearance of 125I-PTH from the blood in the dog. The first two "half-lives" (1.8 and 7 min) accounted for the bulk(More)
Cyclic AMP has been suggested as a possible intracellular mediator in bone remodeling during tooth movement. Accordingly, an increase in the level of this nucleotide should result in faster tooth movement. Breakdown of cAMP was inhibited by administration of diazepam in eight cats undergoing orthodontic tooth movement; another matched group of eight animals(More)
This study used light and scanning electron microscopic (SEM) histomorphometric methods to quantitate the rate of osseointegration of totally porous titanium alloy (Ti-6Al-4V) implants prepared by a novel fabrication technique--electrodischarge compaction (EDC). EDC was used to fuse 150-250-micrometer spherical titanium alloy beads into 4 X 6 mm cylindrical(More)
This is the first in a series of biological investigations using a porous implant fabricated by a novel process known as electrodischarge compaction (EDC). This process uses Ti-6A1-4V powder and electrical energy to construct a beaded porous implant without any compromise in physical characteristics, often found with conventional sintering. The purpose of(More)